Connect with us

Headlines

Sight Sciences Plans $240M IPO

The company’s valuation will be more than $1B.

mm

Published

on

MENLO PARK, CA — Sight Sciences Inc., a medical device company targeting eye diseases, announced the pricing of its initial public offering of 10,000,000 shares of common stock at a public offering price of $24 per share.

All shares of common stock are being offered for total gross proceeds of $240 million, before deducting underwriting discounts and commissions and offering expenses. In addition, Sight Sciences has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Sight Sciences’s stock is expected to begin trading on the Nasdaq Global Market on July 15 under the ticker symbol “SGHT.” The offering is expected to close on July 19, subject to customary closing conditions.

Sight Science had originally looked to raise $160.54 million, MarketWatch reports.

With the increase in price and number of shares, the company’s valuation will be more than $1 billion.

Advertisement

SPONSORED VIDEO

Sponsored by Shamir

Customer Focused, Service Oriented, Forward Thinking

for life improvement, fashion, performance sports, occupational single vision, and progressive lenses. Our values, the driving force behind our ideas and actions, keep the ECP in the center. Every Shamir representative is personally committed to our customers’ vision, and to providing the best service and support to meet and exceed their expectations, all with a personal touch.

Promoted Headlines

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular